{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:24:41Z","timestamp":1780727081639,"version":"3.54.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.cca.2025.120802","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T16:50:49Z","timestamp":1766422249000},"page":"120802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Circular RNAs as biomarkers and targets in ovarian cancer"],"prefix":"10.1016","volume":"582","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-6618","authenticated-orcid":false,"given":"Omji","family":"porwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Visht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozhan Arif","family":"Muhammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2025.120802_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"issue":"182","key":"10.1016\/j.cca.2025.120802_bb0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.24976\/Discov.Med.202436182.60","article-title":"Investigating the spatial distribution of proliferating cells in primary ovarian cancers","volume":"36","author":"Hegazi","year":"2024","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120802_bb0015","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1080\/21655979.2021.2002494","article-title":"Rhophilin rho GTPase binding protein 1-antisense RNA 1 (RHPN1-AS1) promotes ovarian carcinogenesis by sponging microRNA-485-5p and releasing DNA topoisomerase II alpha (TOP2A)","volume":"12","author":"Zhou","year":"2021","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.cca.2025.120802_bb0020","first-page":"183","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"191","key":"10.1016\/j.cca.2025.120802_bb0025","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.24976\/Discov.Med.202436191.224","article-title":"Role of KIF20A depletion in inhibiting ovarian Cancer progression: insights from PTEN and M2 macrophage polarization","volume":"36","author":"Wang","year":"2024","journal-title":"Discov. Med."},{"issue":"4","key":"10.1016\/j.cca.2025.120802_bb0030","article-title":"Early diagnosis of ovarian Cancer: a comprehensive review of the advances, challenges, and future directions","volume":"15","author":"Hong","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0035","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41598-024-52413-9","article-title":"Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cca.2025.120802_bb0040","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.cca.2025.120802_bb0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.14744\/ejmo.2023.32682","article-title":"The cytotoxicity effect of recombinant Arazyme on breast and ovarian cancer cells","volume":"7","author":"Zarei Koosha","year":"2023","journal-title":"Eurasian J. Med. Oncol."},{"key":"10.1016\/j.cca.2025.120802_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annepidem.2021.12.003","article-title":"Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the prostate, lung, colorectal and ovarian Cancer screening trial","volume":"68","author":"King","year":"2022","journal-title":"Ann. Epidemiol."},{"issue":"4","key":"10.1016\/j.cca.2025.120802_bb0055","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian Cancer*","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol. Cell. Proteomics"},{"issue":"3","key":"10.1016\/j.cca.2025.120802_bb0060","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41418-022-00948-7","article-title":"Specific expression and functions of circular RNAs","volume":"29","author":"Misir","year":"2022","journal-title":"Cell Death Differ."},{"issue":"12","key":"10.1016\/j.cca.2025.120802_bb0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s13238-020-00799-3","article-title":"The potential of using blood circular RNA as liquid biopsy biomarker for human diseases","volume":"12","author":"Wen","year":"2021","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0075","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s40001-024-02230-7","article-title":"Circular RNAs as a novel class of potential therapeutic and diagnostic biomarkers in reproductive biology\/diseases","volume":"29","author":"Song","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0080","first-page":"9","article-title":"Preanalytical variables and their influence on the quality of laboratory results","volume":"13","author":"Narayanan","year":"2001","journal-title":"Ejifcc"},{"issue":"Pt 2","key":"10.1016\/j.cca.2025.120802_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2017.12.008","article-title":"Understanding preanalytical variables and their effects on clinical biomarkers of oncology and immunotherapy","volume":"52","author":"Agrawal","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13048-022-00988-0","article-title":"Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer","volume":"15","author":"Ge","year":"2022","journal-title":"J. Ovarian Res."},{"issue":"14","key":"10.1016\/j.cca.2025.120802_bb0095","doi-asserted-by":"crossref","first-page":"14080","DOI":"10.18632\/aging.103388","article-title":"CircRNA FGFR3 induces epithelial-mesenchymal transition of ovarian cancer by regulating miR-29a-3p\/E2F1 axis","volume":"12","author":"Zhou","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.cca.2025.120802_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.784089","article-title":"CircATRNL1 and circZNF608 inhibit ovarian Cancer by sequestering miR-152-5p and encoding protein","volume":"13","author":"Lyu","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0105","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13048-022-00979-1","article-title":"The molecular mechanism of circRHOBTB3 inhibits the proliferation and invasion of epithelial ovarian cancer by serving as the ceRNA of miR-23a-3p","volume":"15","author":"Fu","year":"2022","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.cca.2025.120802_bb0110","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720943613","article-title":"Circular RNA MTO1 inhibits the proliferation and invasion of ovarian Cancer cells through the miR-182-5p\/KLF15 Axis","volume":"29","author":"Wang","year":"2020","journal-title":"Cell Transplant."},{"issue":"14","key":"10.1016\/j.cca.2025.120802_bb0115","doi-asserted-by":"crossref","first-page":"14314","DOI":"10.18632\/aging.103470","article-title":"Circular RNA-9119 suppresses in ovarian cancer cell viability via targeting the microRNA-21-5p-PTEN-Akt pathway","volume":"12","author":"Gong","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.cca.2025.120802_bb0120","doi-asserted-by":"crossref","first-page":"9715","DOI":"10.2147\/OTT.S211413","article-title":"Utility of plasma circBNC2 as a diagnostic biomarker in epithelial ovarian Cancer","volume":"12","author":"Hu","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"10","key":"10.1016\/j.cca.2025.120802_bb0125","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.62347\/KHAK2629","article-title":"Serum hsa_circ_0007534 as a diagnostic biomarker for ovarian cancer","volume":"16","author":"Cao","year":"2024","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cca.2025.120802_bb0130","doi-asserted-by":"crossref","first-page":"7451","DOI":"10.2147\/OTT.S220700","article-title":"Serum circSETDB1 is a promising biomarker for predicting response to platinum-taxane-combined chemotherapy and relapse in high-grade serous ovarian cancer","volume":"12","author":"Wang","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0135","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/07853890.2023.2185289","article-title":"circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b\/c","volume":"55","author":"Liu","year":"2023","journal-title":"Ann. Med."},{"issue":"19","key":"10.1016\/j.cca.2025.120802_bb0140","doi-asserted-by":"crossref","first-page":"19095","DOI":"10.18632\/aging.103706","article-title":"Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells","volume":"12","author":"Wang","year":"2020","journal-title":"Aging"},{"issue":"5","key":"10.1016\/j.cca.2025.120802_bb0145","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e75","article-title":"Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells","volume":"31","author":"Luo","year":"2020","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.cca.2025.120802_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.122000","article-title":"Serum Raman spectroscopy combined with convolutional neural network for rapid diagnosis of HER2-positive and triple-negative breast cancer","volume":"286","author":"Zeng","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"6","key":"10.1016\/j.cca.2025.120802_bb0155","first-page":"2637","article-title":"Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer","volume":"53","author":"Ning","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2025.120802_bb0160","first-page":"276","article-title":"The circular RNA expression profile in ovarian serous cystadenocarcinoma reveals a complex circRNA-miRNA regulatory network","volume":"14","author":"Zhuang","year":"2021","journal-title":"BMC Med. Genet."},{"issue":"11","key":"10.1016\/j.cca.2025.120802_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf505","article-title":"Super-enhancer-mediated circRNAs exhibit high splicing circularization diversity and transcriptional activity","volume":"53","author":"Huang","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0170","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1038\/s41467-025-58607-7","volume":"16","year":"2025","journal-title":"Nat. Commun."},{"issue":"7441","key":"10.1016\/j.cca.2025.120802_bb0175","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature11993","article-title":"Natural RNA circles function as efficient microRNA sponges","volume":"495","author":"Hansen","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.cca.2025.120802_bb0180","first-page":"3713","article-title":"CircHIPK3 is upregulated and predicts a poor prognosis in epithelial ovarian cancer","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"15","key":"10.1016\/j.cca.2025.120802_bb0185","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1080\/15384101.2020.1731650","article-title":"Hsa_circ_0009910: oncogenic circular RNA targets microRNA-145 in ovarian cancer cells","volume":"19","author":"Li","year":"2020","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.cca.2025.120802_bb0190","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/nar\/gkw027","article-title":"Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2","volume":"44","author":"Du","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.cca.2025.120802_bb0195","first-page":"184","article-title":"circRNA circSnx12 confers cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p\/SLC7A11 axis","volume":"56","author":"Qin","year":"2023","journal-title":"BMB Rep."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13048-022-01025-w","article-title":"Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p\/ FBXW7 axis","volume":"15","author":"Liu","year":"2022","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","article-title":"Circ-ZNF609 is a circular RNA that can be translated and functions in Myogenesis","volume":"66","author":"Legnini","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2017.02.021","article-title":"Translation of CircRNAs","volume":"66","author":"Pamudurti","year":"2017","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.cca.2025.120802_bb0215","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/ijc.35523","article-title":"A promising frontier of circulating messenger RNA in liquid biopsy: from mechanisms to clinical applications","volume":"157","author":"Li","year":"2025","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12885-021-09073-z","article-title":"Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer","volume":"22","author":"Ning","year":"2022","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0225","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s12672-024-01602-z","article-title":"Investigating the biomarker value of circRNAs in the diagnosis of colorectal cancer: a systematic review","volume":"15","author":"Latifi-Pakdehi","year":"2024","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0230","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.cca.2025.120802_bb0235","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/cr.2015.82","article-title":"Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0240","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/nat.2022.0040","article-title":"Knockdown of circular RNAs using LNA-modified antisense oligonucleotides","volume":"33","author":"L\u00f8vendorf","year":"2023","journal-title":"Nucleic Acid Ther."},{"issue":"5","key":"10.1016\/j.cca.2025.120802_bb0245","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1007\/s13577-022-00748-8","article-title":"Circular RNA circPBX3 promotes cisplatin resistance of ovarian cancer cells via interacting with IGF2BP2 to stabilize ATP7A mRNA expression","volume":"35","author":"Fu","year":"2022","journal-title":"Hum. Cell"},{"issue":"4","key":"10.1016\/j.cca.2025.120802_bb0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.cca.2025.120802_bb0255","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1021\/acs.jproteome.5c00149","article-title":"Comprehensive comparison of methods for isolation of extracellular vesicles from human plasma","volume":"24","author":"Suresh","year":"2025","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0260","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1038\/s41467-018-05096-6","article-title":"Engineering circular RNA for potent and stable translation in eukaryotic cells","volume":"9","author":"Wesselhoeft","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.cca.2025.120802_bb0265","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molcel.2019.02.015","article-title":"RNA circularization diminishes immunogenicity and can extend translation duration in vivo","volume":"74","author":"Wesselhoeft","year":"2019","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0270","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1038\/s41467-024-53242-0","article-title":"A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice","volume":"15","author":"Liu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2025.120802_bb0275","doi-asserted-by":"crossref","DOI":"10.3788\/COL202018.051701","article-title":"Detection of breast cancer based on novel porous silicon Bragg reflector surface-enhanced Raman spectroscopy-active structure","volume":"18","author":"Ma","year":"2020","journal-title":"Chin. Opt. Lett."},{"key":"10.1016\/j.cca.2025.120802_bb0280","article-title":"Whole blood holding time prior to plasma processing alters microRNA expression profile","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Genet."},{"issue":"7","key":"10.1016\/j.cca.2025.120802_bb0285","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00216-022-04174-5","article-title":"A review on comparative studies addressing exosome isolation methods from body fluids","volume":"415","author":"Martins","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"issue":"20","key":"10.1016\/j.cca.2025.120802_bb0290","doi-asserted-by":"crossref","first-page":"9268","DOI":"10.7150\/thno.46341","article-title":"Instability of circular RNAs in clinical tissue samples impairs their reliable expression analysis using RT-qPCR: from the myth of their advantage as biomarkers to reality","volume":"10","author":"Rochow","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cca.2025.120802_bb0295","doi-asserted-by":"crossref","first-page":"81","DOI":"10.25259\/Cytojournal_59_2025","article-title":"Role of cell division cycle associated 2 in ovarian cancer: effects on tumor progression and cisplatin resistance","volume":"22","author":"Jin","year":"2025","journal-title":"Cytojournal"},{"issue":"8","key":"10.1016\/j.cca.2025.120802_bb0300","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41592-023-01944-6","article-title":"Large-scale benchmarking of circRNA detection tools reveals large differences in sensitivity but not in precision","volume":"20","author":"Vromman","year":"2023","journal-title":"Nat. Methods"},{"issue":"7","key":"10.1016\/j.cca.2025.120802_bb0305","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202202103R","article-title":"Identification of the hub genes in polycystic ovary syndrome based on disease-associated molecule network","volume":"37","author":"Wu","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.cca.2025.120802_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108198","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0315","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","article-title":"A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum","volume":"10","author":"Brennan","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cca.2025.120802_bb0320","doi-asserted-by":"crossref","DOI":"10.1111\/wvn.70048","article-title":"The efficacy of decision aids on enhancing early Cancer screening: a Meta-analysis of randomized controlled trials","volume":"22","author":"Chen","year":"2025","journal-title":"Worldviews Evid.-Based Nurs."},{"issue":"10","key":"10.1016\/j.cca.2025.120802_bb0325","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41592-022-01487-2","article-title":"Best practice standards for circular RNA research","volume":"19","author":"Nielsen","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cca.2025.120802_bb0330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.25259\/Cytojournal_25_2025","article-title":"Mechanistic insights into the effect of midazolam on the malignant progression of ovarian cancer","volume":"22","author":"Sun","year":"2025","journal-title":"Cytojournal"},{"issue":"3","key":"10.1016\/j.cca.2025.120802_bb0335","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.288","article-title":"Evaluation of several methodological challenges in circulating miRNA qPCR studies in patients with head and neck cancer","volume":"50","author":"Poel","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.cca.2025.120802_bb0340","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s42256-024-00868-w","article-title":"A transformer-based weakly supervised computational pathology method for clinical-grade diagnosis and molecular marker discovery of gliomas","volume":"6","author":"Jiang","year":"2024","journal-title":"Nat. Mach. Intel."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-020-01163-z","article-title":"CircMUC16 promotes autophagy of epithelial ovarian cancer via interaction with ATG13 and miR-199a","volume":"19","author":"Gan","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0350","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12871-021-01517-0","article-title":"Circ_MUC16 attenuates the effects of Propofol to promote the aggressive behaviors of ovarian cancer by mediating the miR-1182\/S100B signaling pathway","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Anesthesiol."},{"issue":"3","key":"10.1016\/j.cca.2025.120802_bb0355","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004029","article-title":"CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype","volume":"10","author":"Li","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cca.2025.120802_bb0360","article-title":"Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts","volume":"11","author":"Ricci","year":"2019","journal-title":"Therap. Adv. Med. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2025.120802_bb0365","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41417-025-00941-5","article-title":"Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer","volume":"32","author":"Adams","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"5","key":"10.1016\/j.cca.2025.120802_bb0370","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3892\/ol_00000147","article-title":"Association of ATP7A expression and in vitro sensitivity to cisplatin in non-small cell lung cancer","volume":"1","author":"Inoue","year":"2010","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.cca.2025.120802_bb0375","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molonc.2016.01.003","article-title":"Selective inhibition of tumor cell associated vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells","volume":"10","author":"Kulshrestha","year":"2016","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.cca.2025.120802_bb0380","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/15384101.2021.2010166","article-title":"Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR\/MAPK signaling pathway","volume":"21","author":"Ji","year":"2022","journal-title":"Cell cycle (Georgetown, Tex.)"},{"issue":"18","key":"10.1016\/j.cca.2025.120802_bb0385","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.7150\/jca.46145","article-title":"The application of patient-derived xenograft models in gynecologic cancers","volume":"11","author":"Jiang","year":"2020","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0390","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12967-018-1516-5","article-title":"Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study","volume":"16","author":"Jiang","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cca.2025.120802_bb0395","article-title":"The roles of circMTO1 in Cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Develop. Biol."},{"key":"10.1016\/j.cca.2025.120802_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101746","article-title":"CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR-185-5p\/BMF axis","volume":"36","author":"Liu","year":"2023","journal-title":"Transl. Oncol."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0405","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41420-021-00507-y","article-title":"Effect of circular RNA, mmu_circ_0000296, on neuronal apoptosis in chronic cerebral ischaemia via the miR-194-5p\/Runx3\/Sirt1 axis","volume":"7","author":"Huang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cca.2025.120802_bb0410","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.omtn.2019.12.005","article-title":"circCELSR1 (hsa_circ_0063809) contributes to paclitaxel resistance of ovarian Cancer cells by regulating FOXR2 expression via miR-1252","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0415","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s40001-025-03045-w","article-title":"Circular RNAs: key regulators of paclitaxel sensitivity and resistance in cancer","volume":"30","author":"Tajik","year":"2025","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.cca.2025.120802_bb0420","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.omtn.2020.06.002","article-title":"Circular RNA circTNPO3 regulates paclitaxel resistance of ovarian Cancer cells by miR-1299\/NEK2 signaling pathway","volume":"21","author":"Xia","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"5","key":"10.1016\/j.cca.2025.120802_bb0425","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/CAD.0000000000001058","article-title":"Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p\/SIK2 axis","volume":"32","author":"Wei","year":"2021","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.cca.2025.120802_bb0430","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.2147\/IJN.S505157","article-title":"Exosome-delivered circFOXP1 upregulates autophagy and promotes hepatocellular carcinoma progression through its encoded p196 protein targeting the KHDRBS3\/ULK1 Axis","volume":"20","author":"Zhao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.cca.2025.120802_bb0435","first-page":"1125","article-title":"Tumor-derived exosomal circRNA051239 promotes proliferation and migration of epithelial ovarian cancer","volume":"13","author":"Ma","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.cca.2025.120802_bb0440","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Au Yeung","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.cca.2025.120802_bb0445","doi-asserted-by":"crossref","first-page":"452","DOI":"10.21037\/tcr.2019.03.06","article-title":"The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects","volume":"8","author":"Peng","year":"2019","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0450","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10985549.2022.2160605","article-title":"Exosome-transmitted circIFNGR2 modulates ovarian Cancer metastasis via miR-378\/ST5 Axis","volume":"43","author":"Chen","year":"2023","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.cca.2025.120802_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2023.110703","article-title":"Exosomes derived from ovarian cancer cells regulate proliferation and migration of cancer-associated fibroblasts","volume":"115","author":"Ding","year":"2023","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0460","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/kjm2.12615","article-title":"Exosomal circNFIX promotes angiogenesis in ovarian cancer via miR-518a-3p\/TRIM44 axis","volume":"39","author":"Ye","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.cca.2025.120802_bb0465","doi-asserted-by":"crossref","first-page":"1365928","DOI":"10.3389\/fphar.2024.1365928","article-title":"Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression","volume":"15","author":"Qin","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cca.2025.120802_bb0470","doi-asserted-by":"crossref","first-page":"1629865","DOI":"10.1080\/20013078.2019.1629865","article-title":"Anti-angiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis","volume":"8","author":"Zeng","year":"2019","journal-title":"J. Extracell. Vesicles"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125006813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T08:57:08Z","timestamp":1772355428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125006813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":94,"alternative-id":["S0009898125006813"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120802","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNAs as biomarkers and targets in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120802"}}